Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs

Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma

(2015) William D. Tap et al.   NEOPLASIA

Do Cell-Penetrating Peptides Actually “Penetrate” Cellular Membranes?

(2012) Caroline Palm-Apergi et al.   MOLECULAR THERAPY

CPPsite: a curated database of cell penetrating peptides

(2012) A. Gautam et al.   Database-The Journal of Biological Databases and Curation

Rspo3 Binds Syndecan 4 and Induces Wnt/PCP Signaling via Clathrin-Mediated Endocytosis to Promote Morphogenesis

(2011) Bisei Ohkawara et al.   DEVELOPMENTAL CELL

Tits and bits of HIV Tat protein

(2011) Manish K Johri et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma

(2011) Michael C Kew   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Cell-penetrating peptide exploited syndecans

(2010) Tamás Letoha et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Homing peptides as targeted delivery vehicles

(2010) Pirjo Laakkonen et al.   Integrative Biology

Recent advances in the use of cell-penetrating peptides for medical and biological applications☆

(2009) Sonali B. Fonseca et al.   ADVANCED DRUG DELIVERY REVIEWS

The signaling mechanisms of syndecan heparan sulfate proteoglycans

(2009) Kathleen Lambaerts et al.   CURRENT OPINION IN CELL BIOLOGY

Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

(2008)   CIRCULATION

Syndecan-2 and -4 expressed on activated primary human CD4+ lymphocytes can regulate T cell activation

(2008) Trini Teixé et al.   MOLECULAR IMMUNOLOGY